PharmaForm, Corcept sign manufacturing contract for Korlym
The Korlym has received FDA approval for patients with endogenous Cushing’s syndrome. PharmaForm is a full-service contract provider of development and manufacturing for the pharmaceutical and biotech industry.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.